Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN

Y Shang1, X-X Guo, W-W Li

  • 1Department of Neonatology, First Affiliated Hospital of Xinxiang Medical College, Henan, China. shujunLi01@126.com.

Abstract

Insights

Cucurbitacin-B inhibits neuroblastoma cell growth by up-regulating PTEN and down-regulating AKT signaling. This discovery offers a potential therapeutic strategy for neuroblastoma treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Cucurbitacins are triterpenoids with potential anticancer properties.
  • The specific effects of Cucurbitacin-B on neuroblastoma cells are not well understood.

Purpose of the Study:

  • To investigate the anti-proliferative effects of Cucurbitacin-B in neuroblastoma cells.
  • To elucidate the molecular mechanisms underlying Cucurbitacin-B's action.

Main Methods:

  • Cell proliferation was assessed using MTT and BrdU incorporation assays.
  • Gene and protein expression of cell cycle regulators were analyzed via Real-time PCR and Western blot.
  • PTEN (phosphatase and tensin homolog) gene expression was modulated using small interfering RNAs (siRNAs).

Main Results:

  • Cucurbitacin-B significantly inhibited neuroblastoma (SHSY5Y) cell growth.
  • Cucurbitacin-B modulated the expression of key cell cycle regulators.
  • The compound inhibited AKT signaling by up-regulating PTEN expression, and PTEN deficiency diminished its anti-proliferative effects.

Conclusions:

  • Cucurbitacin-B exhibits anti-proliferative effects in neuroblastoma cells.
  • The mechanism involves the up-regulation of PTEN, leading to the inhibition of AKT signaling.
  • These findings suggest Cucurbitacin-B as a potential therapeutic agent for neuroblastoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.7K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
5.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
39.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K